Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00348244 · ClinicalTrials.gov registry record · Phase 4
Ketorolac vs. Steroid in the Prevention of CME
A Phase 4 study of Cataract, sponsored by Innovative Medical.
- Completed
- Registry status
- Phase 4
- Development phase
- 1
- Study location
NCT00348244 is a Phase 4 study of Cataract that has completed, run by Innovative Medical. The trial reports 1 study location across 1 state.
The verdict
NCT00348244, a Phase 4 study of Cataract, has completed, sponsored by Innovative Medical.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 1
- Study location
Study Summary
Evaluate if the incidence of sub clinical CME can be significantly reduced by use of peri-operative Acular LS plus Pred Forte when compared with Pred Forte alone in normal cataract patients.
Conditions Studied
Interventions
- DRUG Ketorolac, Prednisolone Acetate
Study Locations (1)
New York
- Dr. Wittpenn - Stony Brook
Trial Details
| Field | Value |
|---|---|
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00348244
The ClinicalTrials.gov registry entry for NCT00348244 describes a study currently listed as completed, categorized as Phase 4. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Innovative Medical, which has 44 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cataract appearing as the primary indexed condition, and to 1 intervention - of which Ketorolac, Prednisolone Acetate is the first listed.
NCT00348244 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT00348244 about?
NCT00348244 is a clinical study titled "Ketorolac vs. Steroid in the Prevention of CME". Evaluate if the incidence of sub clinical CME can be significantly reduced by use of peri-operative Acular LS plus Pred Forte when compared with Pred Forte alone in normal cataract patients.
What is the current status of trial NCT00348244?
This trial is currently completed. It is a Phase 4 study.
What conditions does trial NCT00348244 study?
This clinical trial studies the following conditions: Cataract.
What interventions are being tested in trial NCT00348244?
The interventions under investigation include: Ketorolac, Prednisolone Acetate (DRUG).
Who is sponsoring clinical trial NCT00348244?
This trial is sponsored by Innovative Medical, which has 44 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00348244 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cataract
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluating a Dropless Postoperative Regimen After Cataract Surgery in a Vulnerable, County-hospital Population
RECRUITING · Phase 4
-
A Prospective, Randomized, Subject and Vision-assessor Masked, Multicenter Study Comparing Bilateral Clareon PanOptix, Bilateral Clareon PanOptix Pro, and Mixed Clareon PanOptix Pro/Vivity Intraocular Lens Implantation in Cataract Subjects
RECRUITING · Phase 4
-
Evaluation of a Monofocal Intraocular Lens
RECRUITING · Phase 4
-
Evaluate the Safety of DEXYCU for the Treatment of Inflammation Following Ocular Surgery for Childhood Cataract
RECRUITING · Phase 4
-
Odyssey Evaluation in Post LASIK Patients
RECRUITING · Phase 4
-
Dropless vs. Standard Drops Contralateral Eye Study
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.